Author:
Grayson A R,Walsh E M,Cameron M J,Godec J,Ashworth T,Ambrose J M,Aserlind A B,Wang H,Evan G I,Kluk M J,Bradner J E,Aster J C,French C A
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Reference45 articles.
1. Bauer D, Mitchell C, Strait K, Lathan C, Stelow E, Lueer S et al. Clinicopathologic features and long-term outcomes of NUT midline carcinoma. Clin Cancer Res 2012; 18: 5773–5779.
2. French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA . BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res 2003; 63: 304–307.
3. French CA, Ramirez CL, Kolmakova J, Hickman TT, Cameron MJ, Thyne ME et al. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene 2008; 27: 2237–2242.
4. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O et al. Selective inhibition of BET bromodomains. Nature 2010; 468: 1067–1073.
5. Schwartz BE, Hofer MD, Lemieux ME, Bauer DE, Cameron MJ, West NH et al. Differentiation of NUT midline carcinoma by epigenomic reprogramming. Cancer Res 2011; 71: 2686–2696.
Cited by
154 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献